Accelerate Long Island seeded its first batch of startups earlier this year, and today it has circled back with its latest investment—a company purporting to use computer tools to whip up synthetic viruses and create new vaccines.
Accelerate LI and its... Read more »
Ask any app developer about their most soul-crushing experience, and you’re likely to get a story about user reviews.
No matter how powerful or elegant you think the product is, a few minutes in the hands of real-life users are enough... Read more »
How’s this for strange? What’s likely the most important biotech patent battle of the decade is now being fought under outmoded rules that the U.S. Congress, in a rare spasm of common purpose three years ago, agreed roundly were due for... Read more »
With 2014 coming to a close, it’s an appropriate time to reflect on the past year. That’s especially true for me today, as Xconomy celebrates the one-year anniversary of our launch in Wisconsin.
It’s been an eventful 12 months, with... Read more »
Ryan Kuder, a San Diego startup veteran who left the mobile device recycler EcoATM earlier this year, has been hired to lead the new robotics startup accelerator that Qualcomm (NASDAQ: QCOM) is establishing under a deal with Techstars.
Boulder, CO-based... Read more »
Former employees of Elan, the Irish-American drug company that grabbed plenty of headlines before it was broken into parts, have launched a company to develop monoclonal antibodies to treat neurodegenerative disease.
The company is Annexon Bioscience of Redwood City, CA, and... Read more »
Michigan is the second-most agriculturally diverse state in the nation after California, producing everything from blueberries to black beans to begonias. Now, organizers of a new startup accelerator want to add ag-tech software and equipment to that bounty.
Called the Great... Read more »
Eileen Griffith realized that she and her husband were in a rut—and so were her friends.
“Everyone was having the same conversation: What do you want to do?” she recalls. “Everyone was so busy to plan something so it always ends... Read more »
How alluring is the pull of industry these days? Vertex Pharmaceuticals just got one of the world’s top geneticists, a founder of the Broad Institute of MIT and Harvard, to make the switch.
David Altshuler has left his post as the... Read more »